
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
        <link rel="canonical" href="http://spbm.ohio.gainwelltechnologies.com/UPDL%20and%20Supporting%20Documents/Supporting%20Documents/additional_therapeutic/">
      
      
        <link rel="prev" href="../UPDL_criteria/">
      
      
        <link rel="next" href="../payable_active_ingredients/">
      
      
      <link rel="icon" href="../../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.5.36">
    
    
      
        <title>Additional Therapeutic Classes with Clinical Criteria - Ohio SPBM Demo</title>
      
    
    
      <link rel="stylesheet" href="../../../assets/stylesheets/main.06209087.min.css">
      
        
        <link rel="stylesheet" href="../../../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
    <script>__md_scope=new URL("../../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="gainwell" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#additional_therapeutic_classes_with_clinical_criteria" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../../.." title="Ohio SPBM Demo" class="md-header__button md-logo" aria-label="Ohio SPBM Demo" data-md-component="logo">
      
  <img src="../../../img/favicon.ico" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Ohio SPBM Demo
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Additional Therapeutic Classes with Clinical Criteria
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme="gainwell" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6m0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4M7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/gainwell-ohio/spbm/" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    Evergreen
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../../.." class="md-tabs__link">
        
  
    
  
  Welcome

      </a>
    </li>
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Clinical%20and%20Technical%20Reference%20Guide/peer_to_peer/" class="md-tabs__link">
          
  
  Clinical and Technical Reference Guide

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Forms/decision_tree_forms/" class="md-tabs__link">
          
  
  Forms

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Learning%20Materials/Access_and_Maintenance/" class="md-tabs__link">
          
  
  Learning Materials

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Pharmacist%20Reference%20Guide/Links/" class="md-tabs__link">
          
  
  Pharmacist Reference Guide

        </a>
      </li>
    
  

      
        
  
  
    
  
  
    
    
      <li class="md-tabs__item md-tabs__item--active">
        <a href="../../medical_necessity_policy/" class="md-tabs__link">
          
  
  UPDL and Supporting Documents

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Work%20Manager%20Resources/communication_strategies/" class="md-tabs__link">
          
  
  Work Manager Resources

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../about/About/" class="md-tabs__link">
          
  
  About

        </a>
      </li>
    
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../../.." title="Ohio SPBM Demo" class="md-nav__button md-logo" aria-label="Ohio SPBM Demo" data-md-component="logo">
      
  <img src="../../../img/favicon.ico" alt="logo">

    </a>
    Ohio SPBM Demo
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/gainwell-ohio/spbm/" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    Evergreen
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../.." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Welcome
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Clinical%20and%20Technical%20Reference%20Guide/peer_to_peer/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Clinical and Technical Reference Guide
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Forms/decision_tree_forms/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Forms
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Learning%20Materials/Access_and_Maintenance/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Learning Materials
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Pharmacist%20Reference%20Guide/Links/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Pharmacist Reference Guide
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
    
  
  
  
    
    
    
      
        
        
      
      
    
    
      
    
    <li class="md-nav__item md-nav__item--active md-nav__item--section md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6" checked>
        
          
          <label class="md-nav__link" for="__nav_6" id="__nav_6_label" tabindex="">
            
  
  <span class="md-ellipsis">
    UPDL and Supporting Documents
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_6_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_6">
            <span class="md-nav__icon md-icon"></span>
            UPDL and Supporting Documents
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../medical_necessity_policy/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Medical Necessity Policy and Procedures
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../otc_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    OTC List
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Analgesic_Agents/NSAIDs/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Analgesic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../BloodFCT_Agents/colony_stimulating_factors/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    BloodFCT Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../CNS_Agents/alzheimers_agents/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    CNS Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Cardio_Agents/angina_hypertension/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Cardio Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Derma_Agents/oral_acne_products/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Derma Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Endocrine_Agents/androgens/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Endocrine Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Gastro_Agents/anti-emetics/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Gastro Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Genitourinary_Agents/benign_prostatic_hyperplasia/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Genitourinary Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Immuno_Agents/systematic_inflammatory/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Immuno Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Infectious_Disease_Agents/antifungals/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Infectious Disease Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Ophthalmic_Agents/NSAIDs/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Ophthalmic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Otic_Agents/antibacterial/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Otic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Respiratory_Agents/antihistamines/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Respiratory Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
    
  
  
  
    
    
    
      
      
    
    
      
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6_16" checked>
        
          
          <label class="md-nav__link" for="__nav_6_16" id="__nav_6_16_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Supporting Documents
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_6_16_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_6_16">
            <span class="md-nav__icon md-icon"></span>
            Supporting Documents
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Index
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../UPDL_criteria/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    UPDL Criteria
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          
  
  <span class="md-ellipsis">
    Additional Therapeutic Classes with Clinical Criteria
  </span>
  

          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Additional Therapeutic Classes with Clinical Criteria
  </span>
  

      </a>
      
        

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#adrenocorticotropic_hormone_acth_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Adrenocorticotropic Hormone (ACTH) Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#anabolic_steroid" class="md-nav__link">
    <span class="md-ellipsis">
      Anabolic Steroid
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#antimycobacterial" class="md-nav__link">
    <span class="md-ellipsis">
      Antimycobacterial
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#benzothiazole_for_als" class="md-nav__link">
    <span class="md-ellipsis">
      Benzothiazole for ALS
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#central_nervous_system_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Central Nervous System Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#cortisol_receptor_blocker" class="md-nav__link">
    <span class="md-ellipsis">
      Cortisol Receptor Blocker
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#diabetic_insulin_pump" class="md-nav__link">
    <span class="md-ellipsis">
      Diabetic Insulin Pump
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#diarylquinoline_antimycobacterial" class="md-nav__link">
    <span class="md-ellipsis">
      Diarylquinoline Antimycobacterial
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#duchenne_muscular_dystrophy_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Duchenne Muscular Dystrophy Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#endocrine-metabolic_analog" class="md-nav__link">
    <span class="md-ellipsis">
      Endocrine-Metabolic Analog
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#enzyme_replacement_therapy" class="md-nav__link">
    <span class="md-ellipsis">
      Enzyme Replacement Therapy
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#gh_receptor_antagonist" class="md-nav__link">
    <span class="md-ellipsis">
      GH Receptor Antagonist
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#glucocorticoid" class="md-nav__link">
    <span class="md-ellipsis">
      Glucocorticoid
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#glutarimide_immunomodulatory_agent" class="md-nav__link">
    <span class="md-ellipsis">
      Glutarimide Immunomodulatory Agent
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#h-2_antagonist" class="md-nav__link">
    <span class="md-ellipsis">
      H-2 Antagonist
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#inhibitor_of_glucosyleceramide_synthase" class="md-nav__link">
    <span class="md-ellipsis">
      Inhibitor of Glucosyleceramide Synthase
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#insulin-like_growth_factors" class="md-nav__link">
    <span class="md-ellipsis">
      Insulin-like Growth Factors
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#iv_lock_therapy" class="md-nav__link">
    <span class="md-ellipsis">
      IV Lock Therapy
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#lipopeptide_antibacterials" class="md-nav__link">
    <span class="md-ellipsis">
      Lipopeptide Antibacterials
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#long-acting_benzodiazepine" class="md-nav__link">
    <span class="md-ellipsis">
      Long-Acting Benzodiazepine
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#melatonin_receptor_agonist" class="md-nav__link">
    <span class="md-ellipsis">
      Melatonin Receptor Agonist
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#miscellaneous_endocrine_and_metabolic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Miscellaneous Endocrine and Metabolic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#monocolonal_antibody_for_rsv" class="md-nav__link">
    <span class="md-ellipsis">
      Monocolonal Antibody for RSV
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#nasal_synthetic_vasopressin_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Nasal Synthetic Vasopressin Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#oxazolidinone_antibacterial" class="md-nav__link">
    <span class="md-ellipsis">
      Oxazolidinone Antibacterial
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#psoralens" class="md-nav__link">
    <span class="md-ellipsis">
      Psoralens
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#retinoid_x_receptor_activator" class="md-nav__link">
    <span class="md-ellipsis">
      Retinoid X Receptor Activator
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#somatostatin_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Somatostatin Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#spinal_muscular_atrophy_sma" class="md-nav__link">
    <span class="md-ellipsis">
      Spinal Muscular Atrophy (SMA)
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#tetracycline_antibacterials_on_updl" class="md-nav__link">
    <span class="md-ellipsis">
      Tetracycline Antibacterials on UPDL
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#thalidomide_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Thalidomide Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_agents_for_actinic_keratosis" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Agents for Actinic Keratosis
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_agents_treatment_of_anal_fissure" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Agents: Treatment of Anal Fissure
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_-_astringents_protectants" class="md-nav__link">
    <span class="md-ellipsis">
      Topical - Astringents / Protectants
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_retinoid" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Retinoid
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#vitamin_b-12" class="md-nav__link">
    <span class="md-ellipsis">
      Vitamin B-12
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../payable_active_ingredients/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Payable Active Pharmaceutical Compounding Ingredients and Excipients
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../preferred_drug_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Preferred Drug List
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../quantity/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Quantity Limit List
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../specialty_drug_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Specialty Drug List by Therapeutic Class
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../supply_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Supply list
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Topical_Agents/antifungal/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Topical Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../ePA%20Question%20Sets/BloodBlood%20Products%20Hematopoietic%20Agents/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    ePA Question Sets
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Work%20Manager%20Resources/communication_strategies/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Work Manager Resources
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../about/About/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    About
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#adrenocorticotropic_hormone_acth_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Adrenocorticotropic Hormone (ACTH) Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#anabolic_steroid" class="md-nav__link">
    <span class="md-ellipsis">
      Anabolic Steroid
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#antimycobacterial" class="md-nav__link">
    <span class="md-ellipsis">
      Antimycobacterial
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#benzothiazole_for_als" class="md-nav__link">
    <span class="md-ellipsis">
      Benzothiazole for ALS
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#central_nervous_system_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Central Nervous System Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#cortisol_receptor_blocker" class="md-nav__link">
    <span class="md-ellipsis">
      Cortisol Receptor Blocker
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#diabetic_insulin_pump" class="md-nav__link">
    <span class="md-ellipsis">
      Diabetic Insulin Pump
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#diarylquinoline_antimycobacterial" class="md-nav__link">
    <span class="md-ellipsis">
      Diarylquinoline Antimycobacterial
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#duchenne_muscular_dystrophy_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Duchenne Muscular Dystrophy Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#endocrine-metabolic_analog" class="md-nav__link">
    <span class="md-ellipsis">
      Endocrine-Metabolic Analog
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#enzyme_replacement_therapy" class="md-nav__link">
    <span class="md-ellipsis">
      Enzyme Replacement Therapy
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#gh_receptor_antagonist" class="md-nav__link">
    <span class="md-ellipsis">
      GH Receptor Antagonist
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#glucocorticoid" class="md-nav__link">
    <span class="md-ellipsis">
      Glucocorticoid
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#glutarimide_immunomodulatory_agent" class="md-nav__link">
    <span class="md-ellipsis">
      Glutarimide Immunomodulatory Agent
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#h-2_antagonist" class="md-nav__link">
    <span class="md-ellipsis">
      H-2 Antagonist
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#inhibitor_of_glucosyleceramide_synthase" class="md-nav__link">
    <span class="md-ellipsis">
      Inhibitor of Glucosyleceramide Synthase
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#insulin-like_growth_factors" class="md-nav__link">
    <span class="md-ellipsis">
      Insulin-like Growth Factors
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#iv_lock_therapy" class="md-nav__link">
    <span class="md-ellipsis">
      IV Lock Therapy
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#lipopeptide_antibacterials" class="md-nav__link">
    <span class="md-ellipsis">
      Lipopeptide Antibacterials
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#long-acting_benzodiazepine" class="md-nav__link">
    <span class="md-ellipsis">
      Long-Acting Benzodiazepine
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#melatonin_receptor_agonist" class="md-nav__link">
    <span class="md-ellipsis">
      Melatonin Receptor Agonist
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#miscellaneous_endocrine_and_metabolic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Miscellaneous Endocrine and Metabolic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#monocolonal_antibody_for_rsv" class="md-nav__link">
    <span class="md-ellipsis">
      Monocolonal Antibody for RSV
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#nasal_synthetic_vasopressin_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Nasal Synthetic Vasopressin Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#oxazolidinone_antibacterial" class="md-nav__link">
    <span class="md-ellipsis">
      Oxazolidinone Antibacterial
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#psoralens" class="md-nav__link">
    <span class="md-ellipsis">
      Psoralens
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#retinoid_x_receptor_activator" class="md-nav__link">
    <span class="md-ellipsis">
      Retinoid X Receptor Activator
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#somatostatin_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Somatostatin Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#spinal_muscular_atrophy_sma" class="md-nav__link">
    <span class="md-ellipsis">
      Spinal Muscular Atrophy (SMA)
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#tetracycline_antibacterials_on_updl" class="md-nav__link">
    <span class="md-ellipsis">
      Tetracycline Antibacterials on UPDL
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#thalidomide_analogue" class="md-nav__link">
    <span class="md-ellipsis">
      Thalidomide Analogue
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_agents_for_actinic_keratosis" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Agents for Actinic Keratosis
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_agents_treatment_of_anal_fissure" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Agents: Treatment of Anal Fissure
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_-_astringents_protectants" class="md-nav__link">
    <span class="md-ellipsis">
      Topical - Astringents / Protectants
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_retinoid" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Retinoid
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#vitamin_b-12" class="md-nav__link">
    <span class="md-ellipsis">
      Vitamin B-12
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
    <a href="https://github.com/gainwell-ohio/spbm/edit/main/docs/UPDL and Supporting Documents/Supporting Documents/additional_therapeutic.md" title="Edit this page" class="md-content__button md-icon">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20.71 7.04c.39-.39.39-1.04 0-1.41l-2.34-2.34c-.37-.39-1.02-.39-1.41 0l-1.84 1.83 3.75 3.75M3 17.25V21h3.75L17.81 9.93l-3.75-3.75z"/></svg>
    </a>
  
  


<h1 id="additional_therapeutic_classes_with_clinical_criteria">Additional Therapeutic Classes with Clinical Criteria<a class="headerlink" href="#additional_therapeutic_classes_with_clinical_criteria" title="Permanent link">&para;</a></h1>
<p><a :target="_blank" href="https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_AdditionalTherapeuticClasses.pdf#overlay-context=drug-coverage" rel="noopener">Additional Therapeutic Classes with Clinical Criteria</a></p>
<p>Prescribers must provide supporting documentation (chart notes, lab work, medication history) to demonstrate all criteria is satisfied unless specified otherwise. All requests must be in compliance with OAC 5160 &amp; prescribed in accordance with its FDA approved labeling unless specified otherwise.</p>
<p>Authorization is for 365 days unless otherwise stated.</p>
<h2 id="adrenocorticotropic_hormone_acth_analogue">Adrenocorticotropic Hormone (ACTH) Analogue<a class="headerlink" href="#adrenocorticotropic_hormone_acth_analogue" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Acthar®</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must be prescribed by an appropriate specialist</li>
<li>Must have had an inadequate clinical response in the last 30 days or a contraindication to corticosteroid therapy for multiple sclerosis diagnosis</li>
<li>Authorizations will be for up to 28 days</li>
</ul>
<h2 id="anabolic_steroid">Anabolic Steroid<a class="headerlink" href="#anabolic_steroid" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Oxandrolone</li>
</ul>
<p>Clinical Criteria: </p>
<ul>
<li>Must provide documentation that the patient has had ≥ 10% unintentional weight loss AND must be on a high protein diet</li>
<li>Initial authorizations will be for 30 days</li>
<li>Subsequent authorizations require documentation of weight gain with therapy</li>
</ul>
<h2 id="antimycobacterial">Antimycobacterial<a class="headerlink" href="#antimycobacterial" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Priftin® (rifapentine)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must be prescribed by or in consultation with an infectious disease specialist, tuberculosis clinic, CDC or state health department</li>
<li>Must provide documentation of molecular susceptibility testing prior to initiation for an active infection</li>
</ul>
<p><a href="https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/drbark/?h=bark">**Charles Bark, MD</a></p>
<h2 id="benzothiazole_for_als">Benzothiazole for ALS<a class="headerlink" href="#benzothiazole_for_als" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Rilutek® (riluzole)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must be prescribed by or in consultation with a neurologist</li>
</ul>
<h2 id="central_nervous_system_agents">Central Nervous System Agents<a class="headerlink" href="#central_nervous_system_agents" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Nuedexta® </li>
</ul>
<p>(dextromethorphan hydrobromide / quinidine sulfate)</p>
<p>Clinical Criteria:</p>
<ul>
<li>Must havehad an inadequate clinical response or contraindication to a tricyclic antidepressant (TCA) or a selective serotonin reuptake inhibitor (SSRI)</li>
<li>Must provide documentation that patient’s baseline Center for Neurologic Study-Lability Scale (CNS-LS) score &gt; 13 </li>
<li>Initial authorizationswill be for 84 days</li>
<li>Subsequent authorizations require documentation of a positive response to therapy as evidenced by a decrease in the CNS-LS score of ≥ 3 points from baseline</li>
</ul>
<h2 id="cortisol_receptor_blocker">Cortisol Receptor Blocker<a class="headerlink" href="#cortisol_receptor_blocker" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Korlym®</li>
</ul>
<p>(mifepristone)</p>
<p>Clincial Criteria:</p>
<ul>
<li>Must be prescribed by or in consultation with an endocrinologist</li>
<li>Must have documented hyperglycemia secondary to hypercortisolism</li>
<li>Must have had an inadequate clinical response to at least 30 days within the past 60 days or a contraindication to ketoconazole</li>
<li>Initial authorizations will be for 60 days</li>
</ul>
<h2 id="diabetic_insulin_pump">Diabetic Insulin Pump<a class="headerlink" href="#diabetic_insulin_pump" title="Permanent link">&para;</a></h2>
<p>Drug Names:</p>
<ul>
<li>Omnipod® (<mark>Process by NDC</mark>)</li>
<li>V-Go®</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Omnipod may be authorized for diagnoses of Type 1 or 2 Diabetes; V-Go will be limited to a diagnosis of Type 2 Diabetes</li>
<li>Must require insulin injections greater than or equal to 3 times a day and self-home glucose monitoring greater than or equal to 4 times a day</li>
<li>Must be adherent to the insulin therapy recommended by an endocrinologist as demonstrated by monitoring logs and claims history maintained for at least 3 months</li>
<li>Must be capable of managing the pump and that the desired improvement in metabolic control can be achieved (or someone assisting the individual)</li>
<li>Must have completed a comprehensive diabetes education program within the previous 365 days</li>
<li>Must submit a letter or documentation indicating patient regularly works with a certified diabetes educator</li>
<li>Must meet ONE of the following criteria while compliant with insulin regimen:<ul>
<li>HgA1C &gt; 7%</li>
<li>History of recurrent hypoglycemia</li>
<li>Wide fluctuations in blood glucose before mealtime</li>
<li>A marked early morning increase in fasting blood sugar (dawn phenomenon glucose level exceeds 200mg/dL)</li>
<li>History of ketoacidosis</li>
<li>A history of severe glycemic excursions</li>
</ul>
</li>
</ul>
<p><strong>Subsequent authorizations</strong> require documentation of objective evidence of improvement in control of diabetes relative to baseline</p>
<p><a href="https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/omnipod/?h=omnip">Omnipod Quantity Guidance</a></p>
<p><a href="https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7B73347C85-1D40-4514-80E9-9628185B51B4%7D&amp;file=Denial%20Language%20Updated%2001012024.docx&amp;action=embedview&amp;mobiledirect=true&amp;wdStartOn=108" rel="noopener" target="_blank">Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)</a> </br></p>
<h2 id="diarylquinoline_antimycobacterial">Diarylquinoline Antimycobacterial<a class="headerlink" href="#diarylquinoline_antimycobacterial" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Sirturo® (bedaq uiline)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must be prescribed by an Infectious Disease specialist</li>
<li>Must provide documentation of ECG, liver enzymes and electrolytes level prior to authorization</li>
<li>Initial authorizations will be for 14 days and limited to a quantity of 28 or 56 of the 100 mg tablets or a quantity of 140 or 280 of the 20 mg tablets</li>
<li>Subsequent authorizations require documentation of an ECG obtained 2 weeks after initiation and another ECG about 10 weeks later. There must be documentation that the QT interval has been evaluated for continued drug therapy, recommended to be &lt; 500 milliseconds. The remaining 22 weeks of therapy limited to a quantity of 66 or 132 of the 100 mg tablets or a quantity of 330 or 660 of the 20 mg tablets</li>
</ul>
<h2 id="duchenne_muscular_dystrophy_agents">Duchenne Muscular Dystrophy Agents<a class="headerlink" href="#duchenne_muscular_dystrophy_agents" title="Permanent link">&para;</a></h2>
<p>Drug Names:</p>
<ul>
<li>Amondys 45 (casimersen)</li>
<li>Exondys 51 (eteplirsen)</li>
<li>Viltepso (viltolarsen)</li>
<li>Vyondys 53 (golodirsen)</li>
</ul>
<p>Clinical Criteria: </p>
<ul>
<li>Must be prescribed by or in consultation with a neurologist or specialist in Duchenne Muscular Dystrophy</li>
<li>Must receive concurrent corticosteroids unless contraindicated or intolerant</li>
<li>Must provide documentation of genetic testing showing diagnosis with confirmed mutations amenable to exon skipping and the patient's weight</li>
<li>Must provide documentation of appropriate function tests including functional vital capacity (FVC), Brooke Upper Extremity Function score, or equivalent test that demonstrates treatment is likely to improve outcomes</li>
<li>Must provide documentation that drug will be administered at-home</li>
<li>Initial authorizations will be for 180 days</li>
<li>Subsequent authorizations will be for 180 days and requires documentation of appropriate function tests demonstrating clinical improvement or stabilization without deterioration </li>
</ul>
<h2 id="endocrine-metabolic_analog">Endocrine-Metabolic Analog<a class="headerlink" href="#endocrine-metabolic_analog" title="Permanent link">&para;</a></h2>
<p>Drug Name: </p>
<ul>
<li>Sandostatin® (octreotide)</li>
<li>Octreotide, Long-Acting Formulation (Sandostatin LAR)</li>
</ul>
<p>Clinical Criteria:</p>
<p><strong>Sandostatin® (octreotide)</strong></p>
<ul>
<li>Must be prescribed by or in consultation with an endocrinologist or oncologist</li>
<li>Must have a documented baseline IGF-I (somatomedin C) level above normal range for age (level should be re-evaluated at 180-day intervals)</li>
<li>Must not have had an adequate clinical response to surgery, radiation, bromocriptine mesylate OR surgical resection is not an option</li>
<li>Initial authorizations will be up to 90 days</li>
<li>Subsequent authorizations require documentation of clinical response</li>
</ul>
<p><strong>Octreotide, Long-Acting Formulation (Sandostatin LAR)</strong></p>
<ul>
<li>Must be prescribed by or in consultation with an endocrinologist or oncologist</li>
<li>Must have previously treated with short-acting injection for at least 14 days with documented success </li>
<li>Initial authorizations will be for 180 days</li>
<li>Subsequent authorizations require documentation of clinical response</li>
</ul>
<h2 id="enzyme_replacement_therapy">Enzyme Replacement Therapy<a class="headerlink" href="#enzyme_replacement_therapy" title="Permanent link">&para;</a></h2>
<p>for GBA gene mutation disorder</p>
<p>Drug Names: </p>
<ul>
<li>Cerezyme® (imiglucerase)</li>
<li>Elelyso® (taliglucerase alfa)</li>
<li>Vpriv® (velaglucerase alfa)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must not be already receiving another enzyme therapy (e.g., Zavesca, Cerdelga)</li>
<li>Must have baseline, and at least annual,  hemoglobin, platelet count, spleen volume and liver volume tests/examination, DEXA scan</li>
<li>Subsequent authorizations require documentation of clinical response (e.g., decreased liver and spleen volume, increased platelet count, increased hemoglobin concentration)</li>
</ul>
<h2 id="gh_receptor_antagonist">GH Receptor Antagonist<a class="headerlink" href="#gh_receptor_antagonist" title="Permanent link">&para;</a></h2>
<p>Drug Names:</p>
<ul>
<li>Somavert® (pegvisomant)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have had an inadequate clinical response or contraindication to other therapies</li>
<li>Must provide documentation of baseline LFTs </li>
<li>Initial authorizations will be for 180 days</li>
<li>Subsequent authorizations will be for 180 days and require documentation of LFTs</li>
</ul>
<h2 id="glucocorticoid">Glucocorticoid<a class="headerlink" href="#glucocorticoid" title="Permanent link">&para;</a></h2>
<p>Drug Names:</p>
<ul>
<li>Emflaza® (deflazacort)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must be prescribed by or in consultation with a neurologist or specialist in Duchenne Muscular Dystrophy</li>
<li>Must have had an inadequate clinical response of at least 180 days or contraindication to prednisone </li>
<li>Must provide documentation of patient's weight</li>
</ul>
<h2 id="glutarimide_immunomodulatory_agent">Glutarimide Immunomodulatory Agent<a class="headerlink" href="#glutarimide_immunomodulatory_agent" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Thalomid® (thalidomide)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Patient and prescriber must be enrolled in the REMS program</li>
</ul>
<h2 id="h-2_antagonist">H-2 Antagonist<a class="headerlink" href="#h-2_antagonist" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Nizatidine</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have had an inadequate clinical response to at least 30 days or a contraindication with one preferred drug in the past 90 days OR</li>
<li>Patient's condition is clinically unstable or was initiated in hospital to treat a GI bleed or other serious acute condition</li>
<li>Authorizations will be for 84 days unless diagnosis is duodenal ulcer</li>
</ul>
<h2 id="inhibitor_of_glucosyleceramide_synthase">Inhibitor of Glucosyleceramide Synthase<a class="headerlink" href="#inhibitor_of_glucosyleceramide_synthase" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Zavesca® (miglustat)</li>
<li>Cerdelga™ (eliglustat)</li>
</ul>
<p>Clincical Criteria:</p>
<p><strong>Zavesca® (miglustat)</strong></p>
<ul>
<li>Must be unable to receive enzyme therapy due to an allergy, hypersensitivity, or poor venous access</li>
</ul>
<p><strong>Cerdelga™ (eliglustat)</strong></p>
<ul>
<li>Must provide documentation of FDA-cleared test to evaluate cytochrome P450 enzyme (CYP)2D6 functionality and be determined not to be an ultra-rapid metabolizer</li>
<li>Must have baseline, and at least annual, hemoglobin level, platelet count, spleen volume and liver volume tests/examination</li>
<li>Subsequent authorizations require documentation of clinical response or stabilization</li>
</ul>
<h2 id="insulin-like_growth_factors">Insulin-like Growth Factors<a class="headerlink" href="#insulin-like_growth_factors" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Increlex® (mecasermin)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must be prescribed by or in consultation with an endocrinologist</li>
<li>Must not have hypothyroidism or nutritional deficiencies or chronic treatment with pharmacological doses of anti-inflammatory corticosteroids</li>
<li>Subsequent authorizations require documentation of increase in heigh velocity</li>
</ul>
<h2 id="iv_lock_therapy">IV Lock Therapy<a class="headerlink" href="#iv_lock_therapy" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Ablysinol® (dehydrated alcohol)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have a history of catheter-reled bloodstream infections caused by drug resistant pathogens for which there is not a suitable antibiotic lock agent (e.g., fungal)</li>
<li>Replacement of the catheter is not feasible </li>
<li>The patient is TPN dependent or on myelosuppresive chemotherapy</li>
<li>Pharmacy must prepare prefilled syringes of Ablysinol diluted to 70%</li>
<li>Subsequent authorization requires documentation of clinical response (i.e., absence of recurrence of CRBSI or clearing of established infection)</li>
</ul>
<h2 id="lipopeptide_antibacterials">Lipopeptide Antibacterials<a class="headerlink" href="#lipopeptide_antibacterials" title="Permanent link">&para;</a></h2>
<p>Drug Name: </p>
<ul>
<li>Cubicin® (daptomycin)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Authorizations will be up to 42 days as a continuation of therapy if initiated in the hospital</li>
</ul>
<h2 id="long-acting_benzodiazepine">Long-Acting Benzodiazepine<a class="headerlink" href="#long-acting_benzodiazepine" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Xanax XR® (alprazolam, extended release)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have had an inadequate clinical response to other benzodiazepines or is transitioning from other benzodiazepines to alprazolam ER</li>
<li>Initial authorizations will be for 180 days</li>
<li>Subsequent authorizations will be for 180 days and requires documentation of clinical response</li>
</ul>
<h2 id="melatonin_receptor_agonist">Melatonin Receptor Agonist<a class="headerlink" href="#melatonin_receptor_agonist" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Hetlioz® <sup>BVG (<mark>Process by NDC</mark> - Weekly Updates)</sup> (tasimelteon)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must be prescribed by or in consultation with a physician who specializes in the treatment of sleep disorder</li>
<li>Initial and subsequent authorizations will be for 120 days</li>
</ul>
<h2 id="miscellaneous_endocrine_and_metabolic_agents">Miscellaneous Endocrine and Metabolic Agents<a class="headerlink" href="#miscellaneous_endocrine_and_metabolic_agents" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Carnitor® (levocarnitine)**</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have an inadequate clinical response to valproic acid in the past 180 days</li>
</ul>
<p>**<a href="https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/carnitor/?h=carn">Additional Carnitor/Levocarnitine Guidance</a></p>
<h2 id="monocolonal_antibody_for_rsv">Monocolonal Antibody for RSV<a class="headerlink" href="#monocolonal_antibody_for_rsv" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Synagis® (palivizumab)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have a diagnosis of at least one of the following:</li>
<li><strong>Prematurity</strong> - infants born before 29 weeks, 0 day's gestations who are &lt; 12 months of age at the start of RSV season</li>
<li><strong>Chronic Lung Disease</strong><ul>
<li>Infants' gestation age &lt; 32 weeks who are &lt; 12 months of age and require &gt; 21% oxygen for at least the first 28 DAYS after birth</li>
<li>Infants born at &lt; 32 weeks, 0 day's gestation who are ≥ 12 to &lt; 24 months of age who required at least 28 days of &gt; 21% oxygen after birth and who continue to require supplemental oxygen, diuretics, or chronic systemic corticosteroid therapy within 6 months of the start of the second RSV season</li>
</ul>
</li>
<li><strong>Congenital Heart Disease</strong> - infants who are &lt; 12 months of age with a diagnosis of hemodynamically significant heart disease who will most likely benefit from immunoprophylaxis:<ul>
<li>Infants with acyanotic heart disease receiving drugs to control congestive heart failure and who will require surgery</li>
<li>Infants with moderate to sever pulmonary hypertension receiving drugs to control pulmonary hypertension</li>
<li>Infants with a cyanotic heart defect who are prescribed therapy in consultation with a pediatric cardiologist</li>
</ul>
</li>
<li><strong>Congenital abnormalities of the airway or neuromuscular disease</strong> - infants who are &lt; 12 months of age with a diagnosis of a neuromuscular condition that compromises handling of respiratory secretions</li>
<li><strong>Heart Transplant</strong> - patients who are &lt; 24 months of age who have a heart transplant during RSV season</li>
<li><strong>Immunocompromised</strong> - patients who are &lt; 24 months of age who have a diagnosis that supports they are profoundly immunocompromised during the RSV season (e.g. chemotherapy)</li>
<li>Must provide documentation that the patient has not had RSV during the current season </li>
<li>Medication must be requested for use during the RSV season (November 1st to March 31st) AND not to exceed 5 doses per single RSV season or 1 dose per month; whichever is lower</li>
</ul>
<p><a href="https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Clinical%20and%20PA%20Notes/Synagis/Synagis%20Training/?h=syna">Synagis Training</a></p>
<p><a href="https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7B73347C85-1D40-4514-80E9-9628185B51B4%7D&amp;file=Denial%20Language%20Updated%2001012024.docx&amp;action=embedview&amp;mobiledirect=true&amp;wdStartOn=82" rel="noopener" target="_blank">Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)</a> </br></p>
<h2 id="nasal_synthetic_vasopressin_analogue">Nasal Synthetic Vasopressin Analogue<a class="headerlink" href="#nasal_synthetic_vasopressin_analogue" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Stimate® (desmopressin acetate)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must provide documentation of a Stimate challenge test performed prior to initiation</li>
<li>Initial authorizations will be for 30 days</li>
<li>Subsequent authorizations require documentation of clinical response</li>
</ul>
<h2 id="oxazolidinone_antibacterial">Oxazolidinone Antibacterial<a class="headerlink" href="#oxazolidinone_antibacterial" title="Permanent link">&para;</a></h2>
<p>Drug Names:</p>
<p>Zyvox® (linezolid)
Sivextro® (tedizolid)</p>
<p>Clinical Criteria:</p>
<p><strong>Zyvox® (linezolid)</strong></p>
<ul>
<li>Must provide documentation of diagnosis and any culture and sensitivity reports showing the infection is caused by an organism resistant to preferred drugs</li>
<li>For MRSA infections, must have medically valid reason why vancomycin cannot be used</li>
<li>Authorizations will be for 28 days</li>
</ul>
<p><a href="https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7B73347C85-1D40-4514-80E9-9628185B51B4%7D&amp;file=Denial%20Language%20Updated%2001012024.docx&amp;action=embedview&amp;mobiledirect=true&amp;wdStartOn=90" rel="noopener" target="_blank">Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)</a> </p>
<p><strong>Sivextro® (tedizolid)</strong></p>
<ul>
<li>Must provide documentation of diagnosis and any culture and sensitivity reports showing the infection is caused by an organism resistant to preferred drugs</li>
<li>Must have had an inadequate clinical response to linezolid or provide documentation of reasoning the patient cannot be changed to linezolid</li>
<li>Authorizations will be for 6 days</li>
</ul>
<h2 id="psoralens">Psoralens<a class="headerlink" href="#psoralens" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Methoxsalen</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Prescriber must have proper training for use of the UVAR photopheresis system</li>
<li>Must provide documentation of an ophthalmic exam prior to initiation</li>
</ul>
<h2 id="retinoid_x_receptor_activator">Retinoid X Receptor Activator<a class="headerlink" href="#retinoid_x_receptor_activator" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Targretin® <sup>BVG (<mark>Process by NDC</mark> - Weekly Updates)</sup>  (bexarotene)</li>
</ul>
<p>Clinical Criteria</p>
<p><strong>Capsules</strong></p>
<ul>
<li>Must be prescribed by an oncologist</li>
<li>Must have had an inadequate clinical response to at least one prior systemic therapy</li>
<li>Must provide documentation that the patient has had baseline CBC, fasting lipid profile, liver function tests, and thyroid profile prior to initiation</li>
</ul>
<p><strong>Gels</strong></p>
<ul>
<li>Must be prescribed by an oncologist</li>
<li>Must have had an inadequate clinical response to at least 3 of the following:</li>
<li>Local radiation</li>
<li>Phototherapy</li>
<li>Topical carmustine</li>
<li>Topical corticosteroids</li>
<li>Topical imiquimod</li>
<li>Topical mechlorethamine (mustard)</li>
</ul>
<h2 id="somatostatin_analogue">Somatostatin Analogue<a class="headerlink" href="#somatostatin_analogue" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<p>Signifor® (pasireotide)</p>
<p>Clinical Criteria:</p>
<p><strong>Signifor® (pasireotide)</strong></p>
<ul>
<li>Must have a contraindication or an inadequate clinical response of at least 30 days of therapy with ketoconazole, cabergoline, metyrapone, or octreotide within the past 60 days</li>
<li>Must provide documentation that the patient had baseline fasting plasma glucose, hemoglobin A1c, liver function tests, electrocardiogram, gall bladder ultrasound, and electrolyte levels prior to initiation</li>
<li>Initial authorizations will be for 60 days</li>
<li>Subsequent authorizations require documentation of a cortisol level checked 60 days after initiation of therapy</li>
</ul>
<p><strong>Signifor LAR® (pasireotide)</strong></p>
<ul>
<li>Must provide clinical rationale for prescribing Signifor LAR instead of Signifor</li>
<li>Must have had inadequate clinical response to surgery or surgery is not an option</li>
<li>Must provide documentation that the patient had baseline fasting plasma glucose, hemoglobin A1c, liver function tests, electrocardiogram, gall bladder ultrasound, and electrolyte levels prior to initiation</li>
</ul>
<h2 id="spinal_muscular_atrophy_sma">Spinal Muscular Atrophy (SMA)<a class="headerlink" href="#spinal_muscular_atrophy_sma" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Evrysdi™  (risdiplam)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must provide documentation of genetic testing</li>
<li>Must be prescribed by or in consultation with a neurologist</li>
<li>Must not be concomitantly prescribed other treatments for SMA such as Zolgensma or nusinersen</li>
<li>Must provide documentation of inadequate clinical response or contraindication to Zolgensma (e.g., sustained decrease in CHOP-INTEND score over a 6-month period)</li>
<li>Initial authorizations will be up to 365 days</li>
<li>Subsequent authorizations require documentation of clinical response or stabilization</li>
</ul>
<h2 id="tetracycline_antibacterials_on_updl">Tetracycline Antibacterials on UPDL<a class="headerlink" href="#tetracycline_antibacterials_on_updl" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Demeclocycline</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must provide documentation of diagnosis and any culture and sensitivity reports showing the infection is caused by an organism resistant to preferred drugs</li>
<li>Authorizations limited to 28 days</li>
</ul>
<h2 id="thalidomide_analogue">Thalidomide Analogue<a class="headerlink" href="#thalidomide_analogue" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Revlimid® <sup>BVG (<mark>Process by NDC</mark> - Weekly Updates)</sup> (lenalidomide)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Patient and prescriber must be enrolled in the REMS program</li>
</ul>
<h2 id="topical_agents_for_actinic_keratosis">Topical Agents for Actinic Keratosis<a class="headerlink" href="#topical_agents_for_actinic_keratosis" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Aldara® (imiquimod)</li>
<li>Zyclara® (imiquimod)</li>
</ul>
<p>Clinical Criteria:</p>
<p><strong>Aldara® (imiquimod)</strong></p>
<ul>
<li>Must have had an inadequate clincial response to generic imiquimod 5%</li>
<li>Authorizations limited to:</li>
<li>36 single-use packets in a 16-week period for actinic keratosis</li>
<li>36 single-use packets in a 6-week period for superficial basal cell carcinoma</li>
<li>48 single-use packets in a 16-week period for genital or perianal warts</li>
</ul>
<p><strong>Zyclara® (imiquimod)</strong></p>
<ul>
<li>Must have had an inadequate clinical response to generic imiquimod 5%</li>
<li>Authorizations limited to:</li>
<li>56 single-use packets (or two 2.5% or 3.75% 7.5 gram pump bottles) in a 6-week period for actinic keratosis</li>
<li>56 single-use packets (or two 3.75% 7.5 gram pump bottles) in an 8-week period for external genital or perianal warts for a grand total of 16 weeks if needed</li>
</ul>
<h2 id="topical_agents_treatment_of_anal_fissure">Topical Agents: Treatment of Anal Fissure<a class="headerlink" href="#topical_agents_treatment_of_anal_fissure" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Rectiv™ (nitroglycerin)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have had an inadequate clinical response to 14 days of a combination with 3 of the following alternatives: stool softeners, fiber, topical steroid containing product, or topical calcium channel blocker containing product in the past 60 days</li>
<li>Authorizations limited to one fill of ≤ 30-gram tube every 60 days</li>
</ul>
<h2 id="topical_-_astringents_protectants">Topical - Astringents / Protectants<a class="headerlink" href="#topical_-_astringents_protectants" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Qbrexza™ (glycopyrronium)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have a contraindication or an inadequate clinical response of at least 30 days with either Drysol or Xerac-AC Solution</li>
<li>Authorizations limited to 30 cloths per 30 days</li>
</ul>
<h2 id="topical_retinoid">Topical Retinoid<a class="headerlink" href="#topical_retinoid" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Panretin® (alitretinoin)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Initial authorizations will be for 90 days</li>
</ul>
<h2 id="vitamin_b-12">Vitamin B-12<a class="headerlink" href="#vitamin_b-12" title="Permanent link">&para;</a></h2>
<p>Drug Name:</p>
<ul>
<li>Nascobal® (cyanocobalamin)</li>
</ul>
<p>Clinical Criteria:</p>
<ul>
<li>Must have a contraindication or an inadequate clinical response to all injectable formulations of cyanocobalamin</li>
</ul>
<p><strong>All Other Therapies Not Listed Here or on the Unified Preferred Drug List (UPDL)</strong></p>
<ul>
<li>Must be prescribed in accordance with FDA approved labeling</li>
<li>Subsequent authorizations: Must provide documentation of patient's response to treatment from baseline and/or attestation of clinical stabilization</li>
</ul>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../../..", "features": ["navigation.instant", "navigation.tabs", "navigation.prune", "search.highlight", "content.action.edit"], "search": "../../../assets/javascripts/workers/search.6ce7567c.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../../assets/javascripts/bundle.56dfad97.min.js"></script>
      
    
  </body>
</html>